Pro Share Advisors LLC Eq Rx, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $468 - $651	282 Added 0.39%	73,316 $162,000
Q2 2023 Aug 10, 2023	BUY	$1.61 - $1.96 $24,953 - $30,378	15,499 Added 26.94%	73,034 $135,000
Q1 2023 May 11, 2023	SELL	$1.8 - $2.83 $15,710 - $24,700	-8,728 Reduced 13.17%	57,535 $111,000
Q4 2022 Feb 02, 2023	BUY	$2.05 - $5.5 $90,409 - $242,561	44,102 Added 199.01%	66,263 $163,000
Q3 2022 Nov 04, 2022	BUY	$0.94 - $5.99 $6,392 - $40,732	6,800 Added 44.27%	22,161 $109,000
Q2 2022 Aug 01, 2022	BUY	$3.2 - $5.69 $49,155 - $87,404	15,361 New	15,361 $72,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.